c-erbB-2 expression in small-cell lung cancer is associated with poor prognosis.
Open Access
- 13 March 2001
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 92 (4) , 474-479
- https://doi.org/10.1002/ijc.1229
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Second-line chemotherapy and its evaluation in small cell lung cancerCancer Treatment Reviews, 1999
- c-erbB-2 (HER-2/neu) protein and drug resistance in breast cancer patients treated with induction chemotherapyInternational Journal of Cancer, 1999
- Small Cell Lung CancerChest, 1997
- HER‐2/ neu Signal Transduction in Human Breast and Ovarian CancerThe International Journal of Cell Cloning, 1997
- Angiogenesis and molecular biologic substaging in patients with stage I non—small cell lung cancerThe Annals of Thoracic Surgery, 1996
- Receptor Protein-Tyrosine Kinases and Their Signal Transduction PathwaysAnnual Review of Cell Biology, 1994
- Overexpression of the c‐erbB‐2/neu–encoded p185 protein in primary lung cancerMolecular Carcinogenesis, 1992
- Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinomaEuropean Journal of Cancer and Clinical Oncology, 1991
- Long-term Survival and Toxicity in Small Cell Lung CancerChest, 1991
- Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu OncogeneScience, 1985